Exodus Point Capital Management, LP Allakos Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Allakos Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 698,798 shares of ALLK stock, worth $873,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
698,798
Previous 401,729
73.95%
Holding current value
$873,497
Previous $506,000
38.14%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ALLK
# of Institutions
96Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$20.7 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$7.68 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$6.25 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.28 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $106M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...